• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3
3
3
3

COUNTRY

3

CATEGORIES

  • 13
  • 9
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

0
0
18
32

PUBLISHED

0
0
19
32

PRODUCT TYPE

30
2

Search "ReGen Therapeutics Plc-Therapeutic Competitors Report" returned 32 results.

Leukodystrophies - Pipeline Review, H1 2015

Leukodystrophies - Pipeline Review, H1 2015 Summary This, ‘Leukodystrophies - Pipeline Review, H1 2015’, provides an overview of the Leukodystrophies’s therapeutic pipeline. This report provides...

February 2015
FROM

Leukodystrophies - Pipeline Review, H2 2014

Leukodystrophies - Pipeline Review, H2 2014 Summary This, ‘Leukodystrophies - Pipeline Review, H2 2014’, provides an overview of the Leukodystrophies’s therapeutic pipeline. This report provides...

December 2014
FROM

Parkinson's Disease - Pipeline Review, H2 2014

Parkinson's Disease - Pipeline Review, H2 2014 Summary This, ‘Parkinson's Disease - Pipeline Review, H2 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This report...

October 2014
FROM

Alzheimer's Disease - Pipeline Review, H2 2014

Alzheimer's Disease - Pipeline Review, H2 2014 Summary This, ‘Alzheimer's Disease - Pipeline Review, H2 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This report...

October 2014
FROM

Duchenne Muscular Dystrophy - Pipeline Review, H1 2015

Duchenne Muscular Dystrophy - Pipeline Review, H1 2015 Summary This, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Duchenne Muscular Dystrophy’s therapeutic...

January 2015
FROM

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014 Summary This, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014’, provides an overview of the Retinitis Pigmentosa (Retinitis)’s...

November 2014
FROM

Neuropathic Pain - Pipeline Review, H2 2014

Neuropathic Pain - Pipeline Review, H2 2014 Summary This, ‘Neuropathic Pain - Pipeline Review, H2 2014’, provides an overview of the Neuropathic Pain’s therapeutic pipeline. This report provides...

October 2014
FROM

Parkinson's Disease - Pipeline Review, H1 2014

Parkinson's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2014’, provides an overview of the Parkinson's Disease’s therapeutic pipeline. This...

February 2014
FROM

Duchenne Muscular Dystrophy - Pipeline Review, H2 2014

Duchenne Muscular Dystrophy - Pipeline Review, H2 2014 Summary This, ‘Duchenne Muscular Dystrophy - Pipeline Review, H2 2014’, provides an overview of the Duchenne Muscular Dystrophy’s therapeutic...

July 2014
FROM

Duchenne Muscular Dystrophy - Pipeline Review, H1 2014

Duchenne Muscular Dystrophy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2014’, provides an overview of the Duchenne Muscular Dystrophy’s...

February 2014
FROM

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic...

July 2014
FROM

Type 2 Diabetes - Pipeline Review, H1 2014

Type 2 Diabetes - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This...

February 2014
FROM

Hemophilia B - Pipeline Review, H2 2014

Hemophilia B - Pipeline Review, H2 2014 Summary This, ‘Hemophilia B - Pipeline Review, H2 2014’, provides an overview of the Hemophilia B’s therapeutic pipeline. This report provides comprehensive...

August 2014
FROM
Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014 Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014 - Product Thumbnail Image

Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014

Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014 Summary This, ‘Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014’, provides an overview of...

November 2014
FROM

Stroke - Pipeline Review, H1 2014

Stroke - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Stroke - Pipeline Review, H1 2014’, provides an overview of the Stroke’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2014’, provides an overview of the Retinitis Pigmentosa...

March 2014
FROM

Alzheimer's Disease - Pipeline Review, H1 2014

Alzheimer's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This...

February 2014
FROM

Hemophilia A - Pipeline Review, H2 2014

Hemophilia A - Pipeline Review, H2 2014 Summary This, ‘Hemophilia A - Pipeline Review, H2 2014’, provides an overview of the Hemophilia A’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Hemophilia A - Pipeline Review, H1 2014

Hemophilia A - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hemophilia A - Pipeline Review, H1 2014’, provides an overview of the Hemophilia A’s therapeutic pipeline. This report provides...

February 2014
FROM

Hemophilia B - Pipeline Review, H1 2014

Hemophilia B - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hemophilia B - Pipeline Review, H1 2014’, provides an overview of the Hemophilia B’s therapeutic pipeline. This report provides...

March 2014
FROM
Loading Indicator

Our Clients

Goodyear Tire & Rubber Company GlaxoSmithKline PLC Hilton Worldwide Hewlett-Packard Company Accenture PLC. Qualcomm Incorporated UBS AG